We focused on TCGA Pan-Cancer Atlas 2018 dataset (see Methods), which includes RNA-Seq data for 492 PC patients with localised disease, observing that MYCL is expressed in primary prostate tumours. This evidence concerns the gene MYCL and prostate neoplasm.